Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-450
Closed -$357 127
2019
Q1
$357 Buy
+450
New +$33.7K 0.04% 141
2018
Q4
Sell
-443
Closed -$30K 170
2018
Q3
$30K Buy
443
+3
+0.7% +$191 0.03% 155
2018
Q2
$26K Buy
+440
New +$24.8K 0.02% 171

Other funds holding MRK

WP Advisors's MRK Position: Q2 2019 in Review

WP Advisors sold out of Merck (MRK) in Q2 2019, closing a stake of 450 shares — an estimated $357 sold.

WP Advisors first reported a position in MRK in Q2 2018 and held it in 3 quarters. The position peaked at $30K in Q3 2018. 2,299 funds tracked by Wall St. Rank hold MRK as of Q2 2019.

  • WP Advisors reported no remaining Merck position as of Q2 2019 after selling out during the quarter.
  • WP Advisors sold 450 Merck shares in Q2 2019, an estimated $357.
  • WP Advisors first reported a position in Merck in Q2 2018 and held it in 3 quarters.
  • WP Advisors's Merck position peaked at $30K in Q3 2018.
  • 2,299 funds tracked by Wall St. Rank held Merck as of Q2 2019.

Based on WP Advisors's 13F filing for Q2 2019, filed 23 Jul 2019.